Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › rtCGM Usage Is Associated with a Significant Reduction of Time Spent in Hypoglycemia in Patients with Type 1 Diabetes Treated with Multiple Daily Injections—Results of the HypoDE Study

Publication

rtCGM Usage Is Associated with a Significant Reduction of Time Spent in Hypoglycemia in Patients with Type 1 Diabetes Treated with Multiple Daily Injections—Results of the HypoDE Study

Heinemann, Lutz; Freckmann, Guido; Waldenmaier, Delia; u. a. (2018): rtCGM Usage Is Associated with a Significant Reduction of Time Spent in Hypoglycemia in Patients with Type 1 Diabetes Treated with Multiple Daily Injections—Results of the HypoDE Study, in: Diabetes : the journal of the American Diabetes Association, Alexandria, VA., Jg. 67, Nr. Suppl. 1, S. A56 (211-OR), doi: 10.2337/db18-211-OR.

Details

Faculty/Chair
Faculty/Professorship
Author
Heinemann, Lutz
Freckmann, Guido
Waldenmaier, Delia
Title of the Journal
Diabetes : the journal of the American Diabetes Association
ISSN
0012-1797
Corporate Body
American Diabetes Association
Year of publication
2018
Volume
67
Issue
Suppl. 1
Language
English
DOI
URL
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
no
Type
Article
URI
Activation date
2020-01-15

Permalink: https://fis.uni-bamberg.de/handle/uniba/47029 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.